Sickle Cell Disease with Dr. Gregory Vercellotti

Journal of Investigative Medicine Podcast

Inhoud geleverd door BMJ Group. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door BMJ Group of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.

1+ y ago 29:09

MP3•Thuis aflevering

Gearchiveerde serie ("Inactieve feed" status)

When? This feed was archived on October 16, 2023 12:08 (6M ago). Last successful fetch was on July 13, 2023 21:21 (9M ago)

Why? Inactieve feed status. Onze servers konden geen geldige podcast feed ononderbroken ophalen.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

In this conversation with Journal of Investigative Medicine Social Media Editor John Dickinson, MD, PhD, University of Nebraska Medical Center, Gregory Vercellotti, MD, from the University of Minnesota provides an overview of the symptoms, diagnosis and management of sickle cell disease. Dr. Vercellotti is a national leader in the field of vascular biology and cares for adult patients with sickle cell disease. This podcast is especially relevant for primary care physicians, hospitalists, ER physicians, and other subspecialists who may not frequently encounter patients with sickle cell disease.

We discuss many of the common features for symptoms, including pain crises, and complications including stroke, pulmonary hypertension, and avascular necrosis. We also discuss some of the social, economic, and racial factors that are often barriers to effective care. Finally, we discuss some of the promising new options including stem cell transplantation and CRISPR-based cures.

34 afleveringen

#Science #BMJ Group #Jim Editor